Erythropoietin Is Not a Cause of Access Thrombosis
- 1 May 1993
- journal article
- Published by Wiley in Seminars in Dialysis
- Vol. 6 (3) , 180-184
- https://doi.org/10.1111/j.1525-139x.1993.tb00292.x
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Recombinant human erythropoietin treatment improves platelet function in uremic patientsKidney International, 1992
- Vascular Access Thrombosis During Recombinant Human Erythropoietin TherapyAsaio Journal, 1992
- Erythropoietin and spontaneous platelet aggregation in haemodialysis patientsThe Lancet, 1991
- Treatment of Azotemic, Nonoliguric, Anemic Patients with Human Recombinant Erythropoietin Raises Whole-Blood Viscosity Proportional to HematocritNephron, 1991
- Treatment of Transfusion-Dependent Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: A European multicentre study in 142 patients to define dose regimen and safety profileNephrology Dialysis Transplantation, 1991
- Coagulation Studies and Fistula Blood Flow During Erythropoietin Therapy in Haemodialysis PatientsNephrology Dialysis Transplantation, 1991
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Uremic toxins and platelet functionArchives of internal medicine (1960), 1970
- THE BLEEDING DISORDER OF URÆMIA: A Qualitative Platelet DefectThe Lancet, 1966